4 October 2019 - Deborah Wilkes
Archived
Taisho Pharmaceutical has signed an exclusive Japanese licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.